About Us

About Us

About Us

Focal Medical Technology is developing a breakthrough robotic platform for focal prostate cancer treatment using high-precision, image-guided electroporation. Although prostate cancer is the most common cancer in men, current treatments either lack precision in removing tumors, often resulting in their recurrence, or have severe side effects.

Focal Medical Technology is developing a breakthrough robotic platform for focal prostate cancer treatment using high-precision, image-guided electroporation.


Although prostate cancer is the most common cancer in men, current treatments either lack precision in removing tumors, often resulting in their recurrence, or have severe side effects.

Founded in 2022

by serial entrepreneur Dr. Adrian Paz and experienced executive Mr. Nadav Ben Da’at

Backed by Peregrine VC

Supporting and advancing medical innovation through global strategic investments

Executive Team

Executive Team

Executive Team

Dr. Adrian Paz

CMO

Dr. Adrian Paz

CMO

Dr. Adrian Paz

CMO

Dr. Adrian Paz

CMO

Maoz Handelman

CEO

Maoz Handelman

CEO

Maoz Handelman

CEO

Maoz Handelman

CEO

Nadav Ben Da’at

CTO

Nadav Ben Da’at

CTO

Nadav Ben Da’at

CTO

Nadav Ben Da’at

CTO

Advisory Board

Advisory Board

Advisory Board

Prof. Abhinav Sidana

University of Chicago Medicine

Prof. Ben Vanneste

Ghent University

Partner With Us

Together, we can revolutionize the industry and improve patient outcome

Revolutionizing Prostate Cancer Treatment with Precision

info@focalmd.com

6 Yoni Netanyahu, Or Yehuda, Israel

Revolutionizing Prostate Cancer

Treatment with Precision

info@focalmd.com

6 Yoni Netanyahu, Or Yehuda, Israel

Revolutionizing Prostate Cancer Treatment with Precision

info@focalmd.com

6 Yoni Netanyahu, Or Yehuda, Israel

Revolutionizing Prostate Cancer Treatment with Precision

info@focalmd.com

6 Yoni Netanyahu, Or Yehuda, Israel